Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 1/2 4Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 19INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 4Hematologic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parotid Gland Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Lymphoma 1Locally Advanced Rectal Cancer 1Liver Neoplasms 1Leukemia, Plasma Cell 1Immunoglobulin Light-chain Amyloidosis 1Hematologic Diseases 1EGFR Positive Non-small Cell Lung Cancer 1Colorectal Neoplasms 1Burkitt Lymphoma 1Advanced Primary Liver Cancer 1

Interventions

epigallocatechin gallate 1Zinc 1Quercetin 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × OTHER_GOV × Triple Negative Breast Neoplasms × Clear all
NCT05680662 2023-01-11

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Ministry of Health, Saudi Arabia

Phase EARLY_PHASE1 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡